- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/21 - Interferons
Patent holdings for IPC class A61K 38/21
Total number of patents in this class: 2293
10-year publication summary
189
|
172
|
177
|
152
|
165
|
225
|
172
|
159
|
102
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19493 |
34 |
IBC Pharmaceuticals, Inc. | 99 |
31 |
Centre National de La Recherche Scientifique | 10068 |
26 |
Biogen MA Inc. | 912 |
21 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
21 |
Bristol-myers Squibb Company | 4883 |
20 |
Gilead Sciences, Inc. | 1951 |
20 |
Modernatx, Inc. | 1204 |
20 |
ILC Therapeutics Ltd | 27 |
18 |
ellennbe GmbH | 24 |
18 |
Toray Industries, Inc. | 6843 |
17 |
Vib VZW | 845 |
17 |
Iovance Biotherapeutics, Inc. | 315 |
17 |
Universiteit Gent | 1315 |
16 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3038 |
16 |
Enanta Pharmaceuticals, Inc. | 421 |
15 |
Mayo Foundation for Medical Education and Research | 3102 |
14 |
F. Hoffmann-La Roche AG | 7939 |
13 |
The Board of Trustees of the Leland Stanford Junior University | 6229 |
13 |
Superlab Far East Limited | 18 |
13 |
Other owners | 1913 |